Searched for
BHARAT SERUMS TAKEOVER
M&A activity set to remain strong in 2026 after $104 billion domestic consolidation in 2025India's dealmaking activity is poised for a strong 2026, building on a robust 2025. Domestic consolidation and outbound deals surged this y...
Mankind can clear debt taken for BSV buy in 3 years: MD Rajeev JunejaMankind Pharma aims to clear its ₹13,630-crore debt from acquiring Bharat Serums and Vaccines within three years, according to MD Rajeev Ju...
Mankind Pharma is frontrunner in Bharat Serums bidMankind Pharma is in talks to acquire Bharat Serums & Vaccines Ltd., a biopharmaceutical company with brands like Manforce Condoms and Preg...
Advent looking to deploy $5 to $10 billion in India over the next five yearsAdvent International believes that Indian valuations are not a barrier to making deals, as they are relative to growth opportunities and ri...
View: Eminent rise of M&AsDespite the global challenges of high interest rates and geopolitical uncertainties, the economy remains resilient, buoyed by rising domest...
Advent International buys Suven Pharma for Rs 6,313 croreAdvent will also launch an open offer for an additional 26% of the company, a listed contract research and manufacturing services (CRAMS) b...
Poonawalla Finance offers special loans to company secretariesThe non-bank entity is a part of Cyrus Poonawalla group, which owns Serum institute, engaged in developing vaccines for the coronavirus.